About Index Trending news
Analyze
Top 50 Pricing
VentiRx Pharmaceuticals

VentiRx Pharmaceuticals

Work at VentiRx Pharmaceuticals? Add yourself to this profile

VentiRx Pharmaceuticals

VentiRx Pharmaceuticals develops novel TLR8 therapeutics for the treatment of cancer, allergy, and respiratory and autoimmune diseases.

Elsewhere

Alexa global traffic share

Latest funding
Venture capital (Series B)
$50,600,000
Employees

Team size

10+
Locations
HQ
Puget Sound Business Journal , sec

Seattle biopharma startup lands $19.3M in venture funding for cancer research